Home/Filings/4/0000897069-26-000112
4//SEC Filing

Dearborn Dan 4

Accession 0000897069-26-000112

CIK 0001498382other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:35 PM ET

Size

5.6 KB

Accession

0000897069-26-000112

Insider Transaction Report

Form 4
Period: 2026-01-06
Dearborn Dan
Chief Financial Officer
Transactions
  • Award

    Options (Right to Buy)

    2026-01-06+273,696273,696 total
    Exercise: $0.73Exp: 2036-01-06Common Stock (273,696 underlying)
Footnotes (1)
  • [F1]Represents a supplemental option grant to the option grant previously made in December 2025. One-third of the stock options become exercisable on the first, second, and third anniversary of January 6, 2025.

Issuer

TuHURA Biosciences, Inc./NV

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001975443

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:35 PM ET
Size
5.6 KB